According to Immuno-Biological Laboratories latest financial reports the company has an operating margin of 0.07%, an decrease of -138.93% to 2022. At the end of 2022 company had an operating margin of -0.19%.
Year | Operating Margin | Change |
---|---|---|
2023 | 0.07% | -138.93% |
2022 | -0.19% | -52.79% |
2021 | -0.40% | -61.27% |
2020 | -1.03% | - |